Cigna Group FY2025 EPS Estimate Lowered by Cantor Fitzgerald

Cigna Group (NYSE:CI) – Investment analysts at Cantor Fitzgerald dropped their FY2025 EPS estimates for shares of Cigna Group in a report released on Friday, October 31st. Cantor Fitzgerald analyst S. James now forecasts that the health services provider will post earnings per share of $29.60 for the year, down from their previous estimate of $29.66. The consensus estimate for Cigna Group’s current full-year earnings is $29.77 per share.

A number of other research firms also recently issued reports on CI. Jefferies Financial Group restated a “buy” rating and set a $310.00 target price on shares of Cigna Group in a research report on Monday. TD Cowen lowered their price target on shares of Cigna Group from $387.00 to $333.00 and set a “buy” rating for the company in a research report on Tuesday. JPMorgan Chase & Co. lowered their price target on shares of Cigna Group from $428.00 to $375.00 and set an “overweight” rating for the company in a research report on Tuesday. Wells Fargo & Company lifted their price target on shares of Cigna Group from $340.00 to $354.00 and gave the stock an “equal weight” rating in a research report on Tuesday, October 7th. Finally, Barclays lowered their price target on shares of Cigna Group from $383.00 to $300.00 and set an “overweight” rating for the company in a research report on Friday. One analyst has rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating and three have issued a Hold rating to the company’s stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $347.36.

Cigna Group Trading Up 2.0%

CI opened at $263.87 on Monday. The company has a current ratio of 0.71, a quick ratio of 0.71 and a debt-to-equity ratio of 0.65. The stock has a market capitalization of $70.43 billion, a PE ratio of 14.40, a PEG ratio of 0.88 and a beta of 0.45. Cigna Group has a 1-year low of $239.51 and a 1-year high of $350.00. The firm has a 50-day moving average price of $295.64 and a two-hundred day moving average price of $304.84.

Cigna Group (NYSE:CI) last posted its quarterly earnings data on Thursday, October 30th. The health services provider reported $7.83 earnings per share for the quarter, beating the consensus estimate of $7.64 by $0.19. The firm had revenue of $69.57 billion during the quarter, compared to analysts’ expectations of $66.40 billion. Cigna Group had a net margin of 1.92% and a return on equity of 18.80%. The company’s quarterly revenue was up 9.5% compared to the same quarter last year. During the same quarter last year, the company posted $7.51 EPS. Cigna Group has set its FY 2025 guidance at 29.600- EPS.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently made changes to their positions in CI. Valeo Financial Advisors LLC boosted its holdings in shares of Cigna Group by 86,071.1% in the second quarter. Valeo Financial Advisors LLC now owns 3,475,282 shares of the health services provider’s stock valued at $1,148,859,000 after buying an additional 3,471,249 shares during the period. Norges Bank acquired a new position in shares of Cigna Group in the second quarter valued at approximately $1,110,426,000. Nuveen LLC acquired a new position in shares of Cigna Group in the first quarter valued at approximately $727,905,000. Price T Rowe Associates Inc. MD boosted its holdings in shares of Cigna Group by 10.0% in the first quarter. Price T Rowe Associates Inc. MD now owns 12,056,806 shares of the health services provider’s stock valued at $3,966,690,000 after buying an additional 1,094,327 shares during the period. Finally, GQG Partners LLC boosted its holdings in shares of Cigna Group by 21.5% in the first quarter. GQG Partners LLC now owns 4,886,674 shares of the health services provider’s stock valued at $1,607,716,000 after buying an additional 865,092 shares during the period. Institutional investors and hedge funds own 86.99% of the company’s stock.

Insider Activity at Cigna Group

In related news, insider Brian C. Evanko sold 5,368 shares of the business’s stock in a transaction that occurred on Friday, October 3rd. The shares were sold at an average price of $300.00, for a total transaction of $1,610,400.00. Following the completion of the transaction, the insider owned 51,182 shares in the company, valued at approximately $15,354,600. The trade was a 9.49% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO David Cordani bought 4,134 shares of the company’s stock in a transaction on Monday, November 3rd. The shares were bought at an average price of $241.88 per share, for a total transaction of $999,931.92. Following the completion of the acquisition, the chief executive officer directly owned 157,935 shares in the company, valued at approximately $38,201,317.80. This trade represents a 2.69% increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. Corporate insiders own 0.70% of the company’s stock.

Cigna Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, December 18th. Investors of record on Thursday, December 4th will be issued a dividend of $1.51 per share. The ex-dividend date is Thursday, December 4th. This represents a $6.04 dividend on an annualized basis and a yield of 2.3%. Cigna Group’s payout ratio is currently 26.64%.

Cigna Group Company Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.